Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Nuclera Nucleics

Nuclera Nucleics
2013 FOUNDED
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
4 INVESTORS
Description

Owner and operator of a DNA synthesis company intended to create a DNA synthesis platform capable of manufacturing genomes on-demand. The company's platform is based on engineered terminal deoxynucleotidyl transferases and its enzymes are proven to quantitatively incorporate a wide variety of reversibly terminating nucleotide triphosphates of all four nucleobases, enabling users to conduct the production of gene and genome libraries.

Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Social/Platform Software
Other Industries
Biotechnology
Primary Office
  • 152 Cambridge Science Park
  • Milton Road
  • Cambridge CB4 0GN
  • England, United Kingdom
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Nuclera Nucleics’s full profile, request a free trial.

Nuclera Nucleics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Accelerator/Incubator 22-Feb-2017 00000 Completed Generating Revenue
5. Grant 01-Jul-2015 00000 00000 Completed Generating Revenue
4. Grant 01-Jul-2014 000.00 00000 Completed Generating Revenue
3. Grant 01-May-2014 00000 00000 Completed Generating Revenue
2. Accelerator/Incubator $837K Completed Generating Revenue
1. Seed Round 01-May-2014 $837K $837K Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Nuclera Nucleics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Bio-start Accelerator/Incubator Minority 000 0000 000000 0
Nwes Corporation 000 0000 000000 0
Innovate UK Government 000 0000 000000 0
Accelerate Cambridge Accelerator/Incubator 000 0000 000000 0

Nuclera Nucleics Executive Team (3)

Name Title Board
Seat
Contact
Info
Michael Chen Ph.D Co-Founder & Chief Technology Officer
Jiahao Huang Ph.D Co-Founder & Chief Commercial Officer
Gordon McInroy Ph.D Co-Founder & CSO